Expanding Clinical Network + A Unique Approach to Psychedeli $MEDI (Ketamine One) continues to expand their clinical footprint with the recent LOI for 2 ketamine clinics in Texas from Illumma. Located in Austin and Bee Cave, this is a crucial part of $MEDI’s growth in the US.
- $980k estimated cost, paid 50/50 by cash and shares (but is not confirmed since it's still an LOI )
- Illumma is a leading ketamine infusion practice treating individuals with mental health issues, mood disorders and chronic pain issues
https://ca.finance.yahoo.com/news/ketamine-one-signs-loi-two-110000480.html
The clinic expansion is just making it look even cheaper here. Their unique business/therapy model combines tech and psychedelic treatments through VR integration, wearable items to track vitals, and data analytics for research. This helps create a one-of-a-kind treatment.
More on the VR:
https://www.trendhunter.com/trends/ketamin-one
As they continue to grow the business through acquisitions and products, I'll be holding long and strong. IMO their research is second to none, mix that with one of the most expansive clinical networks in NA; it's safe to say that this is undervalued at $1.30. It's only a matter of time when the SP begins to catch up to the business.